ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 697189 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 697189; 2) Community: the network communities that were significantly associated with the response to NSC 697189; 3) Molecule: the relationships between components within communities and NSC 697189; 4) MDR: the compounds that were significantly associated with the NSC 697189.

NSC Compound Enrichment Correlation
NSC 618939 Camptothecin Derivative 3.6295237294955e-006 0.52786593
NSC 368390 Brequinar 3.88440367201721e-005 0.50260624
NSC 619003 MX2 HCl 3.88440367201721e-005 0.48128153
NSC 678914 4-Acridinecarboxamide, N-[2-(dimethylamino)ethyl]- 1-methoxy-, dihydrochloride 3.88440367201721e-005 0.45121795
NSC 710204 Null 4.88335076207314e-005 0.43448695
NSC 733654 6-(3-Chloropropyl)-5,6-dihydro-9-methoxy-3-nitro-5,11-dioxo- 11H-indeno[1,2-c]isoquinoline 4.88335076207314e-005 0.50899218
NSC 646278 Pyrido[3',4':4,5]thieno[2,3-g]isoquinoline, 6-methyl- 4.88335076207318e-005 0.47955787
NSC 740 Methotrexate 4.93279880911877e-006 0.52556366
NSC 725670 5,6-Dihydro-5,11-dioxo-6-(2-N-piperazine-1-ethyl)-11H-indeno [1,2-c]isoquinoline 5.26896645400703e-007 0.36485852
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 6.70485325419773e-005 0.43714867
Total:131  Current:129    [First] [Prev] [Next] [Last]